Pharmacoeconomic considerations in the management of acute tumor lysis syndrome

Seminars in Oncology

Volumn 28, Issue 2 SUPPL. 5, 2001, Pages 19-22

  Farber, Margo S ^a  

^a DETROIT MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; BICARBONATE; GLUCOSE; SODIUM CHLORIDE; URIC ACID;

ALKALINIZATION; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; DRUG COST; HOSPITAL COST; HOSPITALIZATION; HUMAN; HYDRATION; LYMPHOPROLIFERATIVE DISEASE; PATIENT COMPLIANCE; PATIENT SATISFACTION; PRIORITY JOURNAL; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 0035053809     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/sonc.2001.21185     Document Type: Conference Paper

References (14)

1. Pharmacoeconomic principles, methods, and applications to pharmacotherapy
2. Ondansetron: Costs and resource utilization in a US teaching hospital setting
3. Ondansetron: A cost-effective advance in antiemetic therapy
4. ASHP therapeutic guidelines on the pharmacologic management of nausea and vomiting in adult and pediatric patients receiving chemotherapy or radiation therapy or undergoing surgery
5. Filgrastim: A reappraisal of pharmacoeconomic considerations in the prophylaxis and treatment of chemotherapy-induced neutropenia
6. Granulocyte colony-stimulating factor in severe chemotherapy-induced afebrile neutropenia
7. The costs of disease
8. Length of stay and costs for hospitalized hemodialysis patients: Nephrologists versus internists
9. Allopurinol: Intravenous use for prevention and treatment of hyperuricemia
10. Compliance with oral drug therapy in patients with hematologic malignancy
11. Drug delivery and administration
12. Pharmacist-managed intravenous to oral step-down programs
13. Intestinal permeability is increased in burn patients shortly after injury
14. Gastrointestinal permeability and absorptive capacity in sepsis